Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure.
Novitzky-Basso I, Linn SM, White J, Elemary M, Xenocostas A, Deotare U, Kelly K, Hamad N, Tan S, Culos S, Law A, Kumar R, Mattsson J, Kim DDH. Novitzky-Basso I, et al. Among authors: xenocostas a. Bone Marrow Transplant. 2023 Sep;58(9):1024-1032. doi: 10.1038/s41409-023-02020-5. Epub 2023 Jun 26. Bone Marrow Transplant. 2023. PMID: 37365296
Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?
Kawata E, Hedley BD, Chin-Yee B, Xenocostas A, Lazo-Langner A, Hsia CC, Howson-Jan K, Yang P, Levy MA, Santos S, Bhai P, Howlett C, Lin H, Kadour M, Sadikovic B, Chin-Yee I. Kawata E, et al. Among authors: xenocostas a. Int J Lab Hematol. 2022 Apr;44(2):333-341. doi: 10.1111/ijlh.13747. Epub 2021 Oct 29. Int J Lab Hematol. 2022. PMID: 34713980
Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.
Xiao W, Hong H, Kawakami Y, Kato Y, Wu D, Yasudo H, Kimura A, Kubagawa H, Bertoli LF, Davis RS, Chau LA, Madrenas J, Hsia CC, Xenocostas A, Kipps TJ, Hennighausen L, Iwama A, Nakauchi H, Kawakami T. Xiao W, et al. Among authors: xenocostas a. Cancer Cell. 2009 Aug 4;16(2):161-71. doi: 10.1016/j.ccr.2009.05.018. Cancer Cell. 2009. PMID: 19647226 Free PMC article.
Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies.
Bhai P, Hsia CC, Schenkel LC, Hedley BD, Levy MA, Kerkhof J, Santos S, Stuart A, Lin H, Broadbent R, Nan S, Yang P, Xenocostas A, Chin-Yee I, Sadikovic B. Bhai P, et al. Among authors: xenocostas a. Mol Diagn Ther. 2022 May;26(3):333-343. doi: 10.1007/s40291-022-00581-7. Epub 2022 Apr 5. Mol Diagn Ther. 2022. PMID: 35381971
Sam68 Allows Selective Targeting of Human Cancer Stem Cells.
Benoit YD, Mitchell RR, Risueño RM, Orlando L, Tanasijevic B, Boyd AL, Aslostovar L, Salci KR, Shapovalova Z, Russell J, Eguchi M, Golubeva D, Graham M, Xenocostas A, Trus MR, Foley R, Leber B, Collins TJ, Bhatia M. Benoit YD, et al. Among authors: xenocostas a. Cell Chem Biol. 2017 Jul 20;24(7):833-844.e9. doi: 10.1016/j.chembiol.2017.05.026. Epub 2017 Jun 22. Cell Chem Biol. 2017. PMID: 28648376 Free article.
Randomized double-blind safety comparison of intravenous iron dextran versus iron sucrose in an adult non-hemodialysis outpatient population: A feasibility study.
Louzada ML, Hsia CC, Al-Ani F, Ralley F, Xenocostas A, Martin J, Connelly SE, Chin-Yee IH, Minuk L, Lazo-Langner A. Louzada ML, et al. Among authors: xenocostas a. BMC Hematol. 2016 Mar 11;16:7. doi: 10.1186/s12878-016-0046-8. eCollection 2016. BMC Hematol. 2016. PMID: 26973791 Free PMC article.
95 results